| Literature DB >> 11055266 |
H Hakk1, G Larsen, A Bergman, U Orn.
Abstract
1. 14C-TBBP-A (2,2-bis(4-hydroxy-3,5-dibromophenyl)propane) was administered orally to the conventional and bile-duct cannulated male Sprague-Dawley rat (2.0 mg/kg body weight). Urine, bile and faeces were collected daily for 72 h, and selected tissues were removed for distribution studies. 2. Faeces was the major route of elimination of TBBP-A in the conventional rat (91.7% of dose), and urine was a minor elimination route (0.3%). Enterohepatic circulation was suggested by biliary excretion of 71.3% and faecal excretion of 26.7% of the administered radioactivity in the bile-duct cannulated rat. 3. 14C-labelled residues in tissues were 2% in the conventional rat, and < 1% in the bile-duct cannulated rat. The large and small intestines contained the majority of the tissue 14C activity for both groups of rat. Levels of TBBP-A in liver were < 0.1% and in fat were below the level of quantification. 4. Three metabolites were characterized in 0-24 h bile samples. Glucuronic acid and sulphate ester conjugates were characterized by mass spectrometry. More than 95% of the extractable faecal 14C was identified as parent TBBP-A. 5. Negligible amounts of TBBP-A-derived 14C were associated with carrier proteins in the urine and bile.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11055266 DOI: 10.1080/004982500433309
Source DB: PubMed Journal: Xenobiotica ISSN: 0049-8254 Impact factor: 1.908